Figure 2From: Clinical and cost-effectiveness analysis of an open label, single-centre, randomised trial of spinal cord stimulation (SCS) versus percutaneous myocardial laser revascularisation (PMR) in patients with refractory angina pectoris: The SPiRiT trial Mean difference between SCS and PMR in EQ-5D scores at 3, 12 and 24 months post-procedure (values above 0 favour SCS). * Adjusted for baseline.Back to article page